The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

12 Feb 2020 07:00

RNS Number : 6905C
LiDCO Group Plc
12 February 2020
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Lidco Group PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

NO

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 NO

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 NO

An event changing the breakdown of voting rights

NO

Other (please specify):

Periodic update

 NO

3. Full name of person(s) subject to thenotification obligation: iii

Ingalls & Snyder LLC ("I&S") and Ingalls & Snyder Value Partners LP ("ISVP").

4. Full name of shareholder(s) (if different from 3.):iv

I&S, on behalf of its clients, has dispositive authority over (i.e. the power and authorization to sell at I&S's discretion) 17,125,579 shares. In respect of 13,820,000 of such 17,125,579 shares ISVP (as beneficial owner) shares dispositive authority with I&S and has voting authority. So in respect of the 13,820,000 shares beneficially held by ISVP, I&S has and ISVP share dispositive authority and ISVP has voting authority.

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

6. Date on which issuer notified:

February 2, 2020

7. Threshold(s) that is/are crossed orreached: vi, vii

Interest in excess of 7% of issued share capital.

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares of 0.5 pence ISIN GB0030546849

17,125,579

-

17,125,579

See note 4 above. I&S has dispositive authority over 17,125,579shares and ISVP has voting authority and shares dispositive authority in respect of 13,820,000 of such shares.

-

7.01% (Note: For these purposes we have assumed that dispositive authority is equivalent to voting rights).

-

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

N/A

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

17,125,579 (Note: For these purposes we have assumed that dispositive authority is equivalent to voting rights).

7.01% (Note: For these purposes we have assumed that dispositive authority is equivalent to voting rights).

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

N/A

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

14. Contact name:

Frank Stolba

15. Contact telephone number:

(001) (212) 269 - 7814

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLDBGDDSBBDGGB
Date   Source Headline
26th Apr 20107:00 amRNSPreliminary Results
3rd Mar 20104:25 pmRNSSale of Employee Benefit Trust shares
25th Feb 20107:00 amRNSPre-close trading update & notice of Results & AGM
2nd Feb 20107:00 amRNSLiDCO featured in case study from Intel
4th Nov 20097:00 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
29th Oct 20097:00 amRNSInterim Results
19th Oct 20097:00 amRNSAspect launches LiDCOrapid at ASA annual meeting
5th Oct 20097:00 amRNSNotice of Results
5th Oct 20097:00 amRNSWelcomes Covidien acquisition of Aspect Medical
1st Sep 20097:00 amRNSLIDCOrapid chosen for UK OPTIMISE study
19th Aug 20097:00 amRNSTrading Statement
29th Jul 20097:00 amRNSExclusive US-wide distribution agreement
16th Jul 20097:00 amRNSSoftware upgrade for the LiDCOrapid
7th Jul 20091:48 pmRNSIssue of Equity
24th Jun 20095:00 pmRNSTR-1: Notification of Major Interests in Shares
24th Jun 200912:08 pmRNSResult of AGM
28th May 20094:15 pmRNSGrant of Share Options
22nd May 20095:11 pmRNSTR-1: Notifications of Major Interests in Shares
22nd May 20097:00 amRNS2009 Annual Report and Accounts
21st May 20097:00 amRNSIssue of Equity
21st Apr 20097:00 amRNSFinal Results
16th Apr 20097:00 amRNSLiDCO Extends Collaboration With BD
6th Apr 20097:00 amRNSChange of Adviser
10th Mar 20097:00 amRNSDistribution expansion
3rd Mar 200912:47 pmRNSHolding(s) in Company
2nd Mar 20097:00 amRNSNotice of Results and AGM
5th Feb 20094:13 pmRNSHolding(s) in Company
13th Jan 20097:00 amRNSDistribution expansion
30th Oct 20087:01 amRNSInterim Results
30th Oct 20087:00 amRNSLiDCO chosen for clinical trial
28th Oct 20087:00 amRNSDuke University submits US$250,000 order
14th Aug 20087:00 amRNSNew Loan Arrangement and Noti
29th Jul 20087:00 amRNSUS distribution agreement
4th Jul 200812:23 pmRNSHolding(s) in Company
25th Jun 200811:29 amRNSResult of AGM
19th Jun 20087:00 amRNSClinical Evidence
30th May 20087:00 amRNSAnnual Report and Accounts
28th Apr 20084:47 pmPRNDirector/PDMR Shareholding
25th Apr 200811:27 amRNSGrant of Share Options
24th Apr 20087:01 amRNSPreliminary Results
24th Apr 20087:01 amRNSFinance Director Appointment
21st Apr 20087:00 amRNSLaunch of LiDCOrapid Monitor
4th Mar 20087:00 amPRNPreview at World Congress
28th Feb 20087:00 amPRNTrading Update
26th Feb 20087:00 amPRNLiDCOview Pro Launch
25th Feb 20087:00 amPRNNotice of Results
30th Jan 20087:00 amPRNCanadian Distribution Agreement
31st Dec 20079:19 amRNSChange of Adviser
13th Dec 200711:44 amPRNGrant of Options
12th Dec 20077:00 amPRNResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.